Agilent’s second quarter saw a positive market reaction, underpinned by broad-based revenue growth and notable operating margin expansion. Management credited the quarter’s outperformance to strong demand across key end markets, robust instrument sales, and the benefits of its Ignite operating system. CEO Padraig McDonnell highlighted that “replacement site momentum, innovation-led share gains, and improving operational execution” were central to Agilent’s results, while the company’s strategic pricing initiatives and ongoing productivity efforts further supported profitability.
Is now the time to buy A? Find out in our full research report (it’s free for active Edge members).
Agilent (A) Q1 CY2026 Highlights:
- Revenue: $1.84 billion vs analyst estimates of $1.80 billion (10% year-on-year growth, 1.9% beat)
- Adjusted EPS: $1.49 vs analyst estimates of $1.41 (5.8% beat)
- The company slightly lifted its revenue guidance for the full year to $7.44 billion at the midpoint from $7.4 billion
- Management raised its full-year Adjusted EPS guidance to $6.05 at the midpoint, a 1.3% increase
- Operating Margin: 21.7%, up from 18% in the same quarter last year
- Organic Revenue rose 6.3% year on year (beat)
- Market Capitalization: $38.14 billion
While we enjoy listening to the management’s commentary, our favorite part of earnings calls is the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention.
Our Top 5 Analyst Questions From Agilent’s Q1 Earnings Call
- Vijay Kumar (Evercore) asked about the sustainability of CAM growth and instrument strength; CEO Padraig McDonnell credited CAPEX momentum in semiconductors and downstream materials, noting, “investment in the semiconductor space continues to be a real sweet spot for us.”
- Patrick Donnelly (Citi) inquired about visibility and contract coverage in advanced therapeutics; President Simon May responded that “phasing of production schedules point towards very strong year-over-year growth in the third quarter,” with good line of sight into demand for 2027.
- Tycho Peterson (Jefferies) questioned the sustainability of double-digit spectroscopy growth and pricing power; McDonnell cited pent-up demand and new product launches as drivers, describing the semiconductor market as contributing about 30% of advanced materials sales.
- Catherine Schulte (Baird) asked about the food segment’s guidance reduction; McDonnell explained that delayed government spending in China and India, as well as Middle East conflict pressures, were primary factors behind the softness.
- Daniel Brennan (TD Cowen) pressed for detail on the durability of diagnostics growth and Omnis instrument adoption; May emphasized strong execution, double-digit instrument and assay growth, and continued demand in companion diagnostics.
Catalysts in Upcoming Quarters
In future quarters, our team will closely track (1) continued instrument order momentum and the impact of new product launches, (2) realization of operational savings and margin improvement from the Ignite system, and (3) progress on integrating the Biocare acquisition and expanding diagnostics offerings. Additional signposts include stabilization in the food and academic segments and the impact of macroeconomic or geopolitical headwinds on customer capital spending.
Agilent currently trades at $135, up from $115.84 just before the earnings. Is there an opportunity in the stock?Find out in our full research report (it’s free).
Our Favorite Stocks Right Now
ALSO WORTH WATCHING: Top 5 Momentum Stocks. The best time to own a great stock is when the market is finally noticing it. These aren’t just high-quality businesses. Something is happening with them right now. Elite fundamentals meet near-term momentum — both boxes checked at the same time.
Find out which stocks our AI platform is flagging this week. See this week’s Strong Momentum stocks — FREE. Get Our Strong Momentum Stocks for Free HERE.
Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today.
